Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Bosshard

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Urology Focus|October 16, 2020
Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder CancerMarc A Furrer, Thomas Grueter, Piet Bosshard, et al.
International Journal of Cardiology|November 28, 2012
Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?Marzena Zurek, Micha T Maeder, Martin H Brutsche, et al.
Urologic Oncology|January 4, 2020
Complication reporting with the Bern Comprehensive Complication Index CCI after open radical prostatectomy: A longitudinal long-term single-center studyLukas M Löffel, Tobias Gross, Marc P Schneider, et al.
European Urology Oncology|October 2, 2019
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysisMarc A Furrer, Samuel C J Spycher, Sophia M Büttiker, et al.
European Urology Focus|April 23, 2020
Functional Results, Complications Associated with the Serosa-lined Tunnel, and Quality of Life with a Cross-folded Ileal Reservoir Combined with an Afferent Tubular Isoperistaltic Segment for Heterotopic Continent Urinary Diversion: An Observational Long-term Cohort AnalysisMarc A Furrer, Ladina Noser, Benjamin Lyttwin, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
Clinical Chemistry|November 8, 2011
Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarctionNora Schaub, Tobias Reichlin, Christophe Meune, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Oncoimmunology|May 5, 2020
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapyCyrill A Rentsch, Piet Bosshard, Grégoire Mayor, et al.
European Urology Oncology|January 11, 2022
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14Cyrill A Rentsch, George N Thalmann, Ilaria Lucca, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Urology Focus|October 16, 2020
Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder CancerMarc A Furrer, Thomas Grueter, Piet Bosshard, et al.
International Journal of Cardiology|November 28, 2012
Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?Marzena Zurek, Micha T Maeder, Martin H Brutsche, et al.
Urologic Oncology|January 4, 2020
Complication reporting with the Bern Comprehensive Complication Index CCI after open radical prostatectomy: A longitudinal long-term single-center studyLukas M Löffel, Tobias Gross, Marc P Schneider, et al.
European Urology Oncology|October 2, 2019
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysisMarc A Furrer, Samuel C J Spycher, Sophia M Büttiker, et al.
European Urology Focus|April 23, 2020
Functional Results, Complications Associated with the Serosa-lined Tunnel, and Quality of Life with a Cross-folded Ileal Reservoir Combined with an Afferent Tubular Isoperistaltic Segment for Heterotopic Continent Urinary Diversion: An Observational Long-term Cohort AnalysisMarc A Furrer, Ladina Noser, Benjamin Lyttwin, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
Clinical Chemistry|November 8, 2011
Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarctionNora Schaub, Tobias Reichlin, Christophe Meune, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Oncoimmunology|May 5, 2020
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapyCyrill A Rentsch, Piet Bosshard, Grégoire Mayor, et al.
European Urology Oncology|January 11, 2022
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14Cyrill A Rentsch, George N Thalmann, Ilaria Lucca, et al.
Pageof 2